US Pharma MarketingMassBio CEO calls 2025 ‘probably the most challenging year that I can remember’
MassBio report shows MA biopharma jobs fell 3.1%, NIH awards dropped 6%, while China Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the…
Massachusetts is often considered the epicenter of the biotech industry because of its nucleus of world-class research institutions churning out new scientists and new startups.
And it’s for that reason that the data from MassBio’s ...
Source: Endpoints News